KIR2DL2/C1 is a Risk Factor for Chronic Infection and Associated with Non-response to PEG-IFN and RBV Combination Therapy in Hepatitis C Virus Genotype 1b Patients in China

Virologica Sinica ◽

10.1007/s12250-018-0042-1 ◽

2018 ◽

Vol 33 (4) ◽

pp. 369-372

Author(s):

Song Hu ◽

Fahu Yuan ◽

Lingyan Feng ◽

Fang Zheng ◽

Feili Gong ◽

...

Keyword(s):

Risk Factor ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Infection ◽

Virus Genotype ◽

Download Full-text

Efficacy and safety of elbasvir plus grazoprevir combination therapy in Japanese patients infected with hepatitis C virus genotype 1b

Hepatology Research ◽

10.1111/hepr.13242 ◽

2018 ◽

Vol 49 (3) ◽

pp. 256-263 ◽

Author(s):

Yasue Takeuchi ◽

Norio Akuta ◽

Hitomi Sezaki ◽

Fumitaka Suzuki ◽

Shunichiro Fujiyama ◽

...

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Combination Therapy ◽

Japanese Patients ◽

Efficacy And Safety ◽

Virus Genotype ◽

Download Full-text

Rapid Changes in Serum Lipid Profiles during Combination Therapy with Daclatasvir and Asunaprevir in Patients Infected with Hepatitis C Virus Genotype 1b

Gut and Liver ◽

10.5009/gnl17179 ◽

2018 ◽

Vol 12 (2) ◽

pp. 201-207 ◽

Author(s):

Takeshi Chida ◽

Kazuhito Kawata ◽

Kazuyoshi Ohta ◽

Erika Matsunaga ◽

Jun Ito ◽

...

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Combination Therapy ◽

Serum Lipid ◽

Lipid Profiles ◽

Virus Genotype ◽

Genotype 1B ◽

Download Full-text

Daclatasvir and asunaprevir combination therapy for patients with chronic hepatitis C virus genotype 1b infection in real world

The Korean Journal of Internal Medicine ◽

10.3904/kjim.2017.368 ◽

2019 ◽

Vol 34 (4) ◽

pp. 794-801 ◽

Author(s):

Jae Young Oh ◽

Byung Seok Kim ◽

Chang Hyeong Lee ◽

Jeong Eun Song ◽

Heon Ju Lee ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Virus Genotype ◽

Genotype 1B ◽

Chronic Hepatitis C Virus

Download Full-text

Effect and Safety of Daclatasvir-Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b -Infected Patients on Hemodialysis

Therapeutic Apheresis and Dialysis ◽

10.1111/1744-9987.12407 ◽

2016 ◽

Vol 20 (5) ◽

pp. 462-467 ◽

Author(s):

Ryoichi Miyazaki ◽

Kyoko Miyagi

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Virus Genotype ◽

Genotype 1B ◽

Chronic Hepatitis C Virus

Download Full-text

Mutations in the NS5A and E2-PePHD regions of hepatitis C virus genotype 1b and response to combination therapy of interferon plus ribavirin

Liver International ◽

10.1111/j.1478-3231.2003.00875.x ◽

2003 ◽

Vol 23 (6) ◽

pp. 426-433 ◽

Author(s):

Sheng-Shun Yang ◽

Ming-Yang Lai ◽

Ding-Shinn Chen ◽

Gran-Hum Chen ◽

Jia-Horng Kao

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Combination Therapy ◽

Virus Genotype ◽

Download Full-text

Serum 25-hydroxyvitamin D3levels affect treatment outcome in pegylated interferon/ribavirin combination therapy for compensated cirrhotic patients with hepatitis C virus genotype 1b and high viral load

Hepatology Research ◽

10.1111/hepr.12298 ◽

2014 ◽

Vol 44 (13) ◽

pp. 1277-1285 ◽

Author(s):

Masanori Atsukawa ◽

Akihito Tsubota ◽

Noritomo Shimada ◽

Chisa Kondo ◽

Norio Itokawa ◽

...

Keyword(s):

Treatment Outcome ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Combination Therapy ◽

Pegylated Interferon ◽

High Viral Load ◽

Virus Genotype ◽

Genotype 1B ◽

Cirrhotic Patients

Download Full-text

Impact of IL28B polymorphisms on 24-week telaprevir-based combination therapy for Asian chronic hepatitis C patients with hepatitis C virus genotype 1b

Journal of Gastroenterology and Hepatology ◽

10.1111/jgh.12402 ◽

2013 ◽

Vol 29 (1) ◽

pp. 144-150 ◽

Author(s):

Akihito Tsubota ◽

Noritomo Shimada ◽

Masanori Atsukawa ◽

Hiroshi Abe ◽

Keizo Kato ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Virus Genotype ◽

Genotype 1B ◽

Chronic Hepatitis C Patients

Download Full-text

Efficacy of low-dose intermittent interferon-alpha monotherapy in patients infected with hepatitis C virus genotype 1b who were predicted or failed to respond to pegylated interferon plus ribavirin combination therapy

Journal of Medical Virology ◽

10.1002/jmv.21224 ◽

2008 ◽

Vol 80 (8) ◽

pp. 1363-1369 ◽

Author(s):

Norio Akuta ◽

Fumitaka Suzuki ◽

Yusuke Kawamura ◽

Hiromi Yatsuji ◽

Hitomi Sezaki ◽

...

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Combination Therapy ◽

Interferon Alpha ◽

Low Dose ◽

Pegylated Interferon ◽

Virus Genotype ◽

Genotype 1B ◽

Pegylated Interferon Plus Ribavirin

Download Full-text

Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: A meta-analysis

Journal of Hepatology ◽

10.1016/j.jhep.2009.01.019 ◽

2009 ◽

Vol 50 (6) ◽

pp. 1142-1154 ◽

Author(s):

Sara Raimondi ◽

Savino Bruno ◽

Mario U. Mondelli ◽

Patrick Maisonneuve

Keyword(s):

Hepatocellular Carcinoma ◽

Risk Factor ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Meta Analysis ◽

Virus Genotype ◽

Download Full-text

Interferon sensitivity-determining region of nonstructural region 5A of hepatitis C virus genotype 1b correlates with serum alanine aminotransferase levels in chronic infection

Journal of Viral Hepatitis ◽

10.1111/j.1365-2893.2005.00561.x ◽

2005 ◽

Vol 12 (2) ◽

pp. 139-145 ◽

Author(s):

K. Yoshioka ◽

H. Ito ◽

K. Watanabe ◽

M. Yano ◽

M. Ishigami ◽

...

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Alanine Aminotransferase ◽

Chronic Infection ◽

Virus Genotype ◽

Serum Alanine Aminotransferase ◽

Download Full-text